American Journal of Pharmacological Sciences
ISSN (Print): 2327-6711 ISSN (Online): 2327-672X Website: http://www.sciepub.com/journal/ajps Editor-in-chief: Srinivas NAMMI
Open Access
Journal Browser
Go
American Journal of Pharmacological Sciences. 2016, 4(2), 28-30
DOI: 10.12691/ajps-4-2-3
Open AccessArticle

In silico Analysis and Molecular Docking Comparison of Curcumin and Bisdemethoxycurcumin on Transthyretin

Dong-Chan Kim1, 2, and Jae-Ki Ryu1

1Department Biomedical Laboratory Science, Gimcheon University, Gimcheon City, 39528, South Korea

2Institute of Health Science Research, Gimcheon University, Gimcheon City, 39528, South Korea

Pub. Date: March 25, 2016

Cite this paper:
Dong-Chan Kim and Jae-Ki Ryu. In silico Analysis and Molecular Docking Comparison of Curcumin and Bisdemethoxycurcumin on Transthyretin. American Journal of Pharmacological Sciences. 2016; 4(2):28-30. doi: 10.12691/ajps-4-2-3

Abstract

In this study, we investigated and compared the binding affinity of curcumin and its derivative, bisdemethoxycurcumin (BDMC), on the chain A domain of the transthyretin (TTR) protein by computational docking studies. The three dimensional crystallographic structure of TTR was obtained from PDB database (PDB ID: 4PMF). Computational docking analysis was performed using PyRx, Autodock Vina, and Discovery Studio Version 4.5 option based on scoring functions. The curcumin showed optimum binding affinity (docking energy) with TTR with the binding energy of -5.08 kcal/mol as compared to the BDMC (-4.76 kcal/mol). These results indicated that curcumin could be more potent ligands to the TTR than BDMC. Therefore, curcumin can be applied to the fields of the TTR-induced alzheimer's disease regulation.

Keywords:
Alzheimer’s disease bisdemethoxycurcumin curcumin in silico molecular docking transthyretin

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 4

References:

[1]  Goozee KG, Shah TM, Sohrabi HR, Rainey-Smith SR, Brown B, Verdile G, et al. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease. The British journal of nutrition 2016;115:449-65.
 
[2]  Jayaraj RL, Elangovan N, Manigandan K, Singh S, Shukla S. CNB-001 a novel curcumin derivative, guards dopamine neurons in MPTP model of Parkinson's disease. BioMed research international 2014;2014:236182.
 
[3]  Ji HF, Shen L. The multiple pharmaceutical potential of curcumin in Parkinson's disease. CNS & neurological disorders drug targets 2014;13:369-73.
 
[4]  Shwartsman AL, Sarantseva SV. [Compensatory function of transthyretin in Alzheimer's disease]. Tsitologiia 2011;53:772-7.
 
[5]  Vieira M, Saraiva MJ. Transthyretin: a multifaceted protein. Biomolecular concepts 2014;5:45-54.
 
[6]  Saelices L, Johnson LM, Liang WY, Sawaya MR, Cascio D, Ruchala P, et al. Uncovering the Mechanism of Aggregation of Human Transthyretin. J Biol Chem 2015;290:28932-43.
 
[7]  Yokoyama T, Takaki S, Chosa K, Sato T, Suico MA, Teranishi Y, et al. Structural stabilization of transthyretin by a new compound, 6-benzoyl-2-hydroxy-1H-benzo[de]isoquinoline-1,3(2H)-dione. Journal of pharmacological sciences 2015;129:240-3.
 
[8]  Pullakhandam R, Srinivas PN, Nair MK, Reddy GB. Binding and stabilization of transthyretin by curcumin. Archives of biochemistry and biophysics 2009;485:115-9.
 
[9]  Li H, Zhang Y, Cao L, Xiong R, Zhang B, Wu L, et al. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy. Drug design, development and therapy 2014;8:2121-8.
 
[10]  Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry 2010;31:455-61.
 
[11]  Lei Q, Liu H, Peng Y, Xiao P. In silico target fishing and pharmacological profiling for the isoquinoline alkaloids of Macleaya cordata (Bo Luo Hui). Chinese medicine 2015;10:37.
 
[12]  Rohmah RN, Hardiyanti F, Fatchiyah F. Inhibition on JAK-STAT3 Signaling Transduction Cascade Is Taken by Bioactive Peptide Alpha-S2 Casein Protein from Goat Ethawah Breed Milk. Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH 2015;23:233-8.
 
[13]  Sambasivarao SV, Roberts J, Bharadwaj VS, Slingsby JG, Rohleder C, Mallory C, et al. Acetylcholine promotes binding of alpha-conotoxin MII at alpha3 beta2 nicotinic acetylcholine receptors. Chembiochem : a European journal of chemical biology 2014;15:413-24.
 
[14]  Usha T, Middha SK, Goyal AK, Karthik M, Manoj D, Faizan S, et al. Molecular docking studies of anti-cancerous candidates in Hippophae rhamnoides and Hippophae salicifolia. Journal of biomedical research 2014;28:406-15.
 
[15]  Li YB, Gao JL, Zhong ZF, Hoi PM, Lee SM, Wang YT. Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways. Pharmacological reports : PR 2013;65:700-9.
 
[16]  Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008;76:1590-611.